Promoting use of Generic Medicines in the Country
Government of India is aware that despite the orders of the Courts and the relevant regulations of the Medical Council of India, generic medicines are not being prescribed by most medical practitioners. In this regard, clause 1.5 of Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 prescribes that every physician should prescribe drugs […]
Funds for R&D in drug discovery and manufacturing
R&D and innovation in pharma sector is done by number of institutions and organizations under various scientific Ministries/ Departments, which have their own budgetary provisions. Department of Pharmaceuticals has set up seven National Institutes of Pharmaceutical Education & Research (NIPERs) as institutes of national importance, to nurture and promote quality and excellence in pharmaceutical education […]
Pharmaceuticals industry under Atmanirbhar Bharat programme
The Indian Pharmaceutical industry is the 3rd largest in the world by volume. India exported pharmaceuticals worth Rs. 1,75,040 crore in the financial year 2021-22, including Bulk Drugs/ Drug Intermediates. India exported about Rs 33,321 crore and imported Rs 35,249 crore worth APIs and Bulk drugs in 2021-22. In order to make the country Atmanirbhar […]
Bulk Drug Park in the country
Department of Pharmaceuticals implements the Scheme for Promotion of Bulk Drug Parks to facilitate setting up of Three (3) Bulk Drug Parks in the country with the objective to bring down the cost of manufacturing of bulk drugs by creation of world class common infrastructure facilities. The financial assistance by the centre is subject to […]
Government has taken multiple steps to further increase availability of doctors in the country
As per information provided by National Medical Commission (NMC), there are 13,08,009 allopathic doctors registered with the State Medical Councils and the National Medical Commission (NMC) as on June, 2022. Assuming 80% availability of registered allopathic doctors and 5.65 lakh AYUSH doctors, the doctor-population ratio in the country is 1:834 which is better than the […]
National Health Authority to host Hackathon Series under Ayushman Bharat Digital Mission (ABDM)
The National Health Authority (NHA) will be hosting its first ever open-to-all hackathon series to drive ideation and innovations around the different building blocks in the Ayushman Bharat Digital Mission (ABDM) ecosystem. The series will begin with a hackathon - ‘Round 1: Kickstarting Unified Health Interface (UHI)’ slated for 14th to 17th July 2022. The […]
Prime Minister Leads International Yoga Day Celebration with Mass Yoga Demonstration in Mysuru
Prime Minister Shri Narendra Modi marked the 8th International Yoga Day celebration by participating in a Mass Yoga Demonstration involving thousands of participants at Mysuru Palace Ground in Mysuru, Karnataka. Addressing the event at Mysuru, Hon'ble Prime Minister said, "Yoga brings peace to our society, nations, world and Yoga brings peace to our universe. I […]
Lack of innovation set to undermine antibiotic performance and health gains
Development of new antibacterial treatments is inadequate to address the mounting threat of antibiotic resistance, according to the annual pipeline report by the World Health Organization. The 2021 report describes the antibacterial clinical and preclinical pipeline as stagnant and far from meeting global needs. Since 2017 only 12 antibiotics have been approved, 10 of which […]
WHO releases global COVID-19 vaccination strategy update to reach unprotected
The global COVID-19 vaccination rollout is the biggest and fastest in history but many of those at greatest risk remain unprotected – only 28% of older people and 37% of health care workers in low-income countries have received their primary course of vaccines and most have not received booster doses. Health care workers, over 60s […]
CHMP recommends EU approval of Roche’s Vabysmo, the first bispecific antibody for the eye, for two leading causes of vision loss
Vabysmo (faricimab) simultaneously targets and inhibits two disease pathways that drive neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME) The CHMP recommendation is based on results across four phase III studies: TENAYA and LUCERNE in nAMD at year one, and YOSEMITE and RHINE in DME up to two years The totality […]
